Back to results
US 2026/0144863 A1Published application
Vaccine to protect against mycoplasma hyopneumoniae
AssigneeVaxinano SAS
InventorsJohanna Jacoba Elisabeth Bijlsma, Maarten Hendrik Witvliet, Didier Betbeder
Life of this patent
Estimating the term…
Abstract
A vaccine comprising nanoparticles in association with a Mycoplasma hyopneumoniae bacterin, wherein the nanoparticles comprise a cationic polysaccharide and an anionic phospholipid.
Claims15
A vaccine comprising nanoparticles in association with at least one bacterin, wherein the nanoparticles comprise a cationic polysaccharide and an anionic phospholipid and wherein the at least one bacterin is associated to the outside of the nanoparticles via non-covalent attachments.
Dependencies are inferred from the claim text.